SG10201913396RA - Expression constructs and methods for selecting host cells expressing polypeptides - Google Patents

Expression constructs and methods for selecting host cells expressing polypeptides

Info

Publication number
SG10201913396RA
SG10201913396RA SG10201913396RA SG10201913396RA SG10201913396RA SG 10201913396R A SG10201913396R A SG 10201913396RA SG 10201913396R A SG10201913396R A SG 10201913396RA SG 10201913396R A SG10201913396R A SG 10201913396RA SG 10201913396R A SG10201913396R A SG 10201913396RA
Authority
SG
Singapore
Prior art keywords
methods
host cells
cells expressing
expression constructs
expressing polypeptides
Prior art date
Application number
SG10201913396RA
Other languages
English (en)
Inventor
Christel Aebischer-Gumy
Pierre Moretti
Martin Bertschinger
Original Assignee
Ichnos Sciences SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichnos Sciences SA filed Critical Ichnos Sciences SA
Publication of SG10201913396RA publication Critical patent/SG10201913396RA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG10201913396RA 2014-02-28 2015-03-02 Expression constructs and methods for selecting host cells expressing polypeptides SG10201913396RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14157324 2014-02-28

Publications (1)

Publication Number Publication Date
SG10201913396RA true SG10201913396RA (en) 2020-03-30

Family

ID=50184819

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201607114VA SG11201607114VA (en) 2014-02-28 2015-03-02 Expression constructs and methods for selecting host cells expressing polypeptides
SG10201913396RA SG10201913396RA (en) 2014-02-28 2015-03-02 Expression constructs and methods for selecting host cells expressing polypeptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201607114VA SG11201607114VA (en) 2014-02-28 2015-03-02 Expression constructs and methods for selecting host cells expressing polypeptides

Country Status (15)

Country Link
US (2) US20170350886A1 (fr)
EP (1) EP3110950B1 (fr)
JP (1) JP7008406B2 (fr)
KR (1) KR20160135738A (fr)
CN (1) CN106255752A (fr)
AU (1) AU2015222065B2 (fr)
BR (1) BR112016019832A2 (fr)
CA (1) CA2940880C (fr)
EA (1) EA035266B1 (fr)
IL (1) IL247491A0 (fr)
MA (1) MA39502A (fr)
MX (1) MX2016011194A (fr)
NZ (1) NZ723624A (fr)
SG (2) SG11201607114VA (fr)
WO (1) WO2015128509A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2965292T3 (es) * 2015-07-09 2024-04-12 Inst Nat Sante Rech Med Vector lentiviral que expresa anticuerpo anclado a membrana o secretado
CA3026778A1 (fr) * 2016-06-07 2017-12-14 Max-Delbruck-Centrum Fur Molekulare Medizin In Der Helmholtz-Gemeinschaft Recepteur d'antigene chimere et cellules t-car se liant a bcma
JP2020518622A (ja) * 2017-05-02 2020-06-25 アリゲーター・バイオサイエンス・アーベー Ｏｘ４０およびｃｔｌａ−４に対する二重特異性抗体
WO2019169071A1 (fr) * 2018-03-01 2019-09-06 University Of Washington Polypeptides transmembranaires
WO2020005819A1 (fr) * 2018-06-25 2020-01-02 University Of Washington Conception de novo de mimétiques d'interleukine puissants et sélectifs
WO2020260431A1 (fr) 2019-06-28 2020-12-30 F. Hoffmann-La Roche Ag Procédé de production d'anticorps
KR20240038000A (ko) 2021-07-08 2024-03-22 메딕 라이프 사이언시스 인코포레이티드 신규 약물 및 약물 표적 식별을 위한 고처리량 스크리닝 시스템
CN113881701B (zh) * 2021-09-08 2024-04-19 山东大学 一种阳性转染细胞亲和分选方法及试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007251766B2 (en) * 2006-05-17 2013-06-20 F. Hoffmann-La Roche Ag Polypeptide producing cells
WO2009059235A2 (fr) * 2007-11-01 2009-05-07 Facet Biotech Corporation Vecteurs de présentation d'immunoglobulines
US8969539B2 (en) * 2008-06-11 2015-03-03 Jn Biosciences Llc Expression vectors
WO2014126254A1 (fr) * 2013-02-18 2014-08-21 協和発酵キリン株式会社 Vecteur d'expression de protéine de liaison à une membrane

Also Published As

Publication number Publication date
CA2940880C (fr) 2023-09-26
EP3110950A1 (fr) 2017-01-04
SG11201607114VA (en) 2016-09-29
EA035266B1 (ru) 2020-05-22
US20170350886A1 (en) 2017-12-07
MX2016011194A (es) 2017-04-06
AU2015222065A1 (en) 2016-09-15
CA2940880A1 (fr) 2015-09-03
EA201691548A1 (ru) 2017-02-28
JP2017508459A (ja) 2017-03-30
JP7008406B2 (ja) 2022-01-25
EP3110950B1 (fr) 2022-09-21
CN106255752A (zh) 2016-12-21
AU2015222065B2 (en) 2021-05-20
NZ723624A (en) 2022-07-29
IL247491A0 (en) 2016-11-30
WO2015128509A1 (fr) 2015-09-03
KR20160135738A (ko) 2016-11-28
MA39502A (fr) 2015-09-03
US20190056396A1 (en) 2019-02-21
BR112016019832A2 (pt) 2017-10-17

Similar Documents

Publication Publication Date Title
IL282168A (en) Factor VIII chimeric proteins and their uses
IL248361B (en) Recombinant host cell for expression of desired proteins
IL249373A0 (en) Polypeptide formulations of related detector and method
IL247491A0 (en) Expression constructs and methods for selecting host cells expressing polypeptides
LT3212660T (lt) Žinduolio ląstelės, ekspresuojančios citomegaloviruso antigenus
HK1248272A1 (zh) 宿主細胞蛋白質修飾
LT3131577T (lt) Modifikuotos ląstelės-šeimininkės ir jų naudojimas
EP3107996A4 (fr) Cellules tscm et leurs procédés d'utilisation
IL249368A0 (en) map44 polypeptides and structures based on natural antibodies and their uses
IL246642A0 (en) Materials and methods for quantifying pld-1 protein levels
SG11201606501PA (en) Nanobody-fluorescent protein fusion
EP3140275A4 (fr) Antagonistes de bh4 et procédés associés à ceux-ci
GB201419897D0 (en) Host cell
GB201403913D0 (en) Proteins
GB201403914D0 (en) Proteins
GB201403912D0 (en) Proteins